Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.
Baratchian M, Tiwari R, Khalighi S, Chakravarthy A, Yuan W, Berk M, Li J, Guerinot A, de Bono J, Makarov V, Chan TA, Silverman RH, Stark GR, Varadan V, De Carvalho DD, Chakraborty AA, Sharifi N. Baratchian M, et al. Among authors: chan ta. Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2114324119. doi: 10.1073/pnas.2114324119. Epub 2022 May 18. Proc Natl Acad Sci U S A. 2022. PMID: 35584120 Free PMC article.
Pursuing Immunotherapeutic Targets in SCLC.
Dowlati A, Chan T. Dowlati A, et al. J Thorac Oncol. 2021 Jul;16(7):1056-1057. doi: 10.1016/j.jtho.2021.04.017. J Thorac Oncol. 2021. PMID: 34154789 Free article. No abstract available.
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
Hou Y, Zhou Y, Gack MU, Lathia JD, Kallianpur A, Mehra R, Chan TA, Jung JU, Jehi L, Eng C, Cheng F. Hou Y, et al. Among authors: chan ta. Signal Transduct Target Ther. 2021 Jul 30;6(1):292. doi: 10.1038/s41392-021-00709-x. Signal Transduct Target Ther. 2021. PMID: 34330889 Free PMC article. Clinical Trial.
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19.
Zhou Y, Hou Y, Shen J, Kallianpur A, Zein J, Culver DA, Farha S, Comhair S, Fiocchi C, Gack MU, Mehra R, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F. Zhou Y, et al. ChemRxiv [Preprint]. 2020 Jul 2. doi: 10.26434/chemrxiv.12579137. ChemRxiv. 2020. PMID: 32676577 Free PMC article. Updated. Preprint.
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
Zhou Y, Hou Y, Shen J, Mehra R, Kallianpur A, Culver DA, Gack MU, Farha S, Zein J, Comhair S, Fiocchi C, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F. Zhou Y, et al. PLoS Biol. 2020 Nov 6;18(11):e3000970. doi: 10.1371/journal.pbio.3000970. eCollection 2020 Nov. PLoS Biol. 2020. PMID: 33156843 Free PMC article.
292 results